Evolution of Facial Trauma During COVID Containment Measures

NCT ID: NCT04355442

Last Updated: 2020-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-01

Study Completion Date

2020-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The COVID-19 global pandemic has led to a major professional and social national reorganization: professional because it involves a redeployment of medical staff and material resources, and social because it imposes prolonged containment measures on an entire population.

The maxillofacial trauma activity is mainly linked to sports or leisure accidents, fights and road accidents.

It seems to appear since the beginning of containment measures a significant drop in maxillofacial trauma activity at the national level, which, if it is demonstrated in a significant way in several French hospital centers, would allow to redeploy the material and human resources related to this activity on sectors in tension due to the pandemic.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will compare maxillo-facial activity during the first month of COVID-19 containment measures in France with a comparable period in 2018 and 2019. This comparison will be made in 10 major French hospital centers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Maxillofacial Injuries Skull Fractures COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

contained patients

contained patients

Facial fractures reduction or osteosynthesis

Intervention Type PROCEDURE

Facial fractures reduction or osteosynthesis

Comparative patients

Comparative patients

Facial fractures reduction or osteosynthesis

Intervention Type PROCEDURE

Facial fractures reduction or osteosynthesis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Facial fractures reduction or osteosynthesis

Facial fractures reduction or osteosynthesis

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Maxillo-facial fracture
* Requiring
* Trauma that occured between March 16 and April 15, 2020 or 2018 or 2019
* All ages

Exclusion Criteria

* Patients who refused the collection of their data
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unités de CMF des CHU de Paris (Dr Davrou - Pitié salpetrière)

UNKNOWN

Sponsor Role collaborator

Amiens (Dr Dapke)

UNKNOWN

Sponsor Role collaborator

Nantes (Pr Corre)

UNKNOWN

Sponsor Role collaborator

Toulouse (Pr Lauwers - Purpan)

UNKNOWN

Sponsor Role collaborator

Marseille (Dr Foletti - La conception)

UNKNOWN

Sponsor Role collaborator

Nice (Dr Savoldelli)

UNKNOWN

Sponsor Role collaborator

Clermont Ferrand (Dr Sesque)

UNKNOWN

Sponsor Role collaborator

Perpignan (Dr Llobet)

UNKNOWN

Sponsor Role collaborator

Lyon (Dr Bourlet - Croix Rousse)

UNKNOWN

Sponsor Role collaborator

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marie de BOUTRAY, PH

Role: STUDY_DIRECTOR

UH MONTPELLIER

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Uh Montpellier

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RECHMPL20_0228

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.